The Patent Finder

Terms ending in 2029

Pharma Cinq, LLC

Every in-force patent on Pharma Cinq, LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,115,072Compounds and Method for Reducing Uric Acid
In force (reinstated)
 · High confidence
Pharma Cinq, LLCIn force (reinstated)High confidence
US 8,178,675Compounds for the Treatment of Metabolic Disorders
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
US 8,889,724Tetrazole Compounds for Reducing Uric Acid
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
US 8,557,531Detection of Circulating Endothelial Cells
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
US 8,481,595Compounds for the Treatment of Metabolic Disorders
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited